Search

Your search keyword '"Tönges, L."' showing total 170 results

Search Constraints

Start Over You searched for: Author "Tönges, L." Remove constraint Author: "Tönges, L."
170 results on '"Tönges, L."'

Search Results

6. P-99 Nerve conduction studies in a cohort of patients with Parkinson[StQuote]s disease, multiple system atrophy and progressive supranuclear palsy

10. P 35. Nerve conduction studies and their clinical relevance in a cohort of patients with Parkinson's disease

11. FV 7. Cross-sectional area of the vagus nerve correlates with parasympathetic dysfunction in Parkinson's Disease

13. Association of Blood Pressure with Outcomes in Acute Stroke Thrombectomy

18. Alpha-synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons

19. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS

22. Measurement of the bottom-strange meson mixing phase in the full CDF data set

23. Guidelines for the use and interpretation of assays for monitoring autophagy

27. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.

28. Longitudinal evaluation of polyneuropathy in Parkinson's disease.

29. The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy.

30. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.

32. [Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment].

33. A Short Progressive Supranuclear Palsy Quality of Life Scale.

34. Guideline "Parkinson's disease" of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care.

35. [How the implementation of a school for people with Parkinson's disease can succeed-Results of a consensus study and a formative evaluation].

36. Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries.

37. The comorbidity and co-medication profile of patients with progressive supranuclear palsy.

38. Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021.

39. Data-driven subtyping of Parkinson's disease: comparison of current methodologies and application to the Bochum PNS cohort.

40. Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson's disease and atypical Parkinsonian syndromes.

41. Quality Control-A Stepchild in Quantitative Proteomics: A Case Study for the Human CSF Proteome.

42. Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson's disease.

43. [Adenosine A2A Receptor Antagonists as a Treatment Option for Parkinson's Disease?]

44. Parkinson's disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study.

45. [Relevance of COMT inhibitors in the treatment of motor fluctuations].

46. Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

47. COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.

49. Residents as teachers in Neurology: a Germany-wide survey on the involvement of neurological residents in clinical teaching.

50. SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review.

Catalog

Books, media, physical & digital resources